CDT Equity Inc. (CDT) SEC filings
CDT SEC filings moved a median of -1.21% by the close. CDT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CDT overview →
115 measured CDT SEC filing events.
Where these CDT SEC filings landedvs 113 measured CDT SEC filing reactions
| Middle 50% of CDT SEC filing reactions | -4.82% to +1.53% |
|---|---|
| Median reaction (to close) | -1.21% |
| Measured reactions | 113 |
Point-in-time · zero look-ahead
Half of the 113 CDT SEC filing events with a measured close landed between -4.82% and +1.53%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form PRE 14A CDT Equity Inc. For: Oct 16 | SEC filing · Form PRE | — | — | |
| CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset | Press release | +0.74% | -1.15% | |
| Form 8-K CDT Equity Inc. For: Oct 06 | SEC filing · Form 8-K | -8.40% | -23.90% | |
| Form 8-K CDT Equity Inc. For: Sep 24 | SEC filing · Form 8-K | -2.15% | -9.50% | |
| Form 8-K CDT Equity Inc. For: Sep 14 | SEC filing · Form 8-K | +1.75% | -7.23% | |
| Form EFFECT CDT Equity Inc. | SEC filing · Form EFFECT | +1.93% | +8.07% | |
| Form S-1 CDT Equity Inc. | SEC filing · Form S-1 | -1.67% | +0.02% | |
| Form 8-K CDT Equity Inc. For: Aug 31 | SEC filing · Form 8-K | +3.30% | +2.80% | |
| Form 8-K CDT Equity Inc. For: Aug 28 | SEC filing · Form 8-K | -3.07% | -9.20% | |
| CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio | Press release | -1.01% | -14.65% | |
| Form 8-K/A CDT Equity Inc. For: Feb 19 | SEC filing · Form 8-K | +1.70% | -2.72% | |
| Form 8-K/A CDT Equity Inc. For: Jul 30 | SEC filing · Form 8-K | +1.70% | -2.72% | |
| Form 10-Q CDT Equity Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +4.49% | |
| Form DEFA14A CDT Equity Inc. | SEC filing · Form DEFA14A | — | +4.49% | |
| Form ARS CDT Equity Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | -4.82% | |
| Form DEF 14A CDT Equity Inc. For: Aug 11 | SEC filing · Form DEF | +0.00% | -4.82% | |
| Form 8-K CDT Equity Inc. For: Jul 31 | SEC filing · Form 8-K | +0.00% | +5.56% | |
| Form 8-K/A CDT Equity Inc. For: Jul 30 | SEC filing · Form 8-K | +2.26% | +10.56% | |
| Form 8-K CDT Equity Inc. For: Jul 30 | SEC filing · Form 8-K | +2.76% | -1.21% | |
| Form PRE 14A CDT Equity Inc. For: Jul 31 | SEC filing · Form PRE | +2.76% | -1.21% | |
| Form 8-K CDT Equity Inc. For: Jul 24 | SEC filing · Form 8-K | -1.32% | +1.13% | |
| Form 8-K CDT Equity Inc. For: Jul 15 | SEC filing · Form 8-K | -4.50% | +11.63% | |
| Form 10-Q CDT Equity Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.50% | +11.63% | |
| Form 8-K CDT Equity Inc. For: Jun 30 | SEC filing · Form 8-K | +2.33% | +2.74% | |
| Form 8-K CDT Equity Inc. For: Jun 23 | SEC filing · Form 8-K | +0.02% | -3.43% | |
| CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development | Press release | +2.53% | -5.22% | |
| Form 8-K CDT Equity Inc. For: Jun 11 | SEC filing · Form 8-K | +0.00% | -5.07% | |
| Form 8-K CDT Equity Inc. For: May 21 | SEC filing · Form 8-K | +0.00% | -5.46% | |
| Form 8-K CDT Equity Inc. For: May 15 | SEC filing · Form 8-K | +1.22% | -12.28% | |
| Form NT 10-Q CDT Equity Inc. For: Mar 31 | SEC filing · Form NT | +1.22% | -12.28% | |
| Form EFFECT CDT Equity Inc. | SEC filing · Form EFFECT | -0.91% | -4.98% | |
| Form 8-K CDT Equity Inc. For: Apr 27 | SEC filing · Form 8-K | — | -1.60% | |
| Form S-3 CDT Equity Inc. | SEC filing · Form S-3 | -0.92% | -4.28% | |
| Form 10-K CDT Equity Inc. For: Dec 31 | SEC filing · Form 10-K | -0.25% | -12.62% | |
| Form NT 10-K CDT Equity Inc. For: Dec 31 | SEC filing · Form NT | +1.33% | -4.13% | |
| Form 8-K CDT Equity Inc. For: Mar 24 | SEC filing · Form 8-K | -5.84% | +5.91% | |
| Form 8-K CDT Equity Inc. For: Mar 17 | SEC filing · Form 8-K | +0.00% | -5.75% | |
| Form 8-K CDT Equity Inc. For: Mar 03 | SEC filing · Form 8-K | -3.79% | -10.64% | |
| Form DEF 14A CDT Equity Inc. For: Mar 06 | SEC filing · Form DEF | — | +4.34% | |
| Form 8-K CDT Equity Inc. For: Feb 19 | SEC filing · Form 8-K | -1.46% | -0.01% | |
| Form PRE 14A CDT Equity Inc. For: Feb 24 | SEC filing · Form PRE | -1.46% | -0.01% | |
| Form EFFECT CDT Equity Inc. | SEC filing · Form EFFECT | +0.45% | +0.00% | |
| Form S-3 CDT Equity Inc. | SEC filing · Form S-3 | +4.59% | +0.00% | |
| Form S-8 CDT Equity Inc. | SEC filing · Form S-8 | +4.59% | +0.00% | |
| Form 8-K CDT Equity Inc. For: Jan 16 | SEC filing · Form 8-K | -0.78% | -6.20% | |
| CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy | Press release | -1.54% | +10.77% | |
| Form 8-K CDT Equity Inc. For: Dec 28 | SEC filing · Form 8-K | +0.69% | -2.78% | |
| Form 8-K CDT Equity Inc. For: Dec 08 | SEC filing · Form 8-K | -1.14% | +0.57% | |
| Form S-8 POS CDT Equity Inc. | SEC filing · Form S-8 | -1.14% | +0.57% | |
| Form 8-K CDT Equity Inc. For: Oct 08 | SEC filing · Form 8-K | -0.41% | +1.53% | |
| Form 10-Q CDT Equity Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.32% | -2.38% | |
| Form 10-Q/A CDT Equity Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.32% | -2.38% | |
| Form 8-K CDT Equity Inc. For: Aug 08 | SEC filing · Form 8-K | +0.60% | +0.00% | |
| Form S-8 CDT Equity Inc. | SEC filing · Form S-8 | +1.16% | — | |
| Form 8-K CDT Equity Inc. For: Aug 04 | SEC filing · Form 8-K | +0.00% | -6.04% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | +0.00% | -1.07% | |
| Form S-3 CONDUIT PHARMACEUTICALS | SEC filing · Form S-3 | +0.00% | -0.55% | |
| Form DEF 14A CONDUIT PHARMACEUTICALS For: Jul 08 | SEC filing · Form DEF | +0.31% | -1.77% | |
| Form ARS CONDUIT PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +2.08% | -1.67% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Jun 03 | SEC filing · Form 8-K | +2.15% | -1.19% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Jun 03 | SEC filing · Form 8-K | -3.92% | -4.63% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: May 15 | SEC filing · Form 8-K | -0.40% | +3.31% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +2.15% | +4.35% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: May 05 | SEC filing · Form 8-K | +0.26% | -10.23% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | +2.29% | +3.21% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Apr 24 | SEC filing · Form 8-K | +0.54% | -2.59% | |
| Form DEF 14A CONDUIT PHARMACEUTICALS For: Apr 25 | SEC filing · Form DEF | +0.54% | -2.59% | |
| Form S-3 CONDUIT PHARMACEUTICALS | SEC filing · Form S-3 | -0.79% | -0.63% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Apr 12 | SEC filing · Form 8-K | -2.31% | -3.11% | |
| Form PRE 14A CONDUIT PHARMACEUTICALS For: Apr 16 | SEC filing · Form PRE | -2.31% | -3.11% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 8-K | -0.73% | +3.78% | |
| Form 8-K/A CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 8-K | +0.00% | -2.09% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 8-K | -1.09% | -0.41% | |
| Form 10-K CONDUIT PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -21.90% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Mar 05 | SEC filing · Form 8-K | -0.01% | +0.92% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Feb 12 | SEC filing · Form 8-K | -0.84% | -2.46% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | -2.23% | -8.94% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Feb 07 | SEC filing · Form 8-K | +3.26% | -3.80% | |
| Form S-8 CONDUIT PHARMACEUTICALS | SEC filing · Form S-8 | -4.89% | +6.34% | |
| Form S-3 CONDUIT PHARMACEUTICALS | SEC filing · Form S-3 | +2.75% | -10.40% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Jan 22 | SEC filing · Form 8-K | -5.59% | -0.20% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Jan 13 | SEC filing · Form 8-K | -3.67% | -5.56% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Dec 17 | SEC filing · Form 8-K | -5.83% | -9.17% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Dec 12 | SEC filing · Form 8-K | -5.13% | -11.25% | |
| Form DEF 14A CONDUIT PHARMACEUTICALS For: Dec 06 | SEC filing · Form DEF | +2.65% | -0.33% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | +2.65% | -0.33% | |
| Form PRE 14A CONDUIT PHARMACEUTICALS For: Nov 26 | SEC filing · Form PRE | +6.33% | +9.99% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Nov 22 | SEC filing · Form 8-K | +0.23% | +5.06% | |
| Form S-3 CONDUIT PHARMACEUTICALS | SEC filing · Form S-3 | +0.23% | +5.06% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | -0.22% | +0.22% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 10-Q/A CONDUIT PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 10-Q/A CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.11% | -2.96% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Nov 12 | SEC filing · Form 8-K | -0.11% | -2.96% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | -2.89% | +9.44% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Oct 28 | SEC filing · Form 8-K | -2.89% | +9.44% | |
| Form DEFA14A CONDUIT PHARMACEUTICALS | SEC filing · Form DEFA14A | -2.89% | +9.44% | |
| Form ARS CONDUIT PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +4.19% | -0.19% | |
| Form DEF 14A CONDUIT PHARMACEUTICALS For: Oct 28 | SEC filing · Form DEF | +4.19% | -0.19% | |
| Form DEFA14A CONDUIT PHARMACEUTICALS | SEC filing · Form DEFA14A | +4.19% | -0.19% | |
| Form S-3 CONDUIT PHARMACEUTICALS | SEC filing · Form S-3 | +0.55% | +11.18% | |
| Form PRE 14A CONDUIT PHARMACEUTICALS For: Oct 16 | SEC filing · Form PRE | +1.80% | -4.06% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Oct 09 | SEC filing · Form 8-K | +0.20% | +13.27% | |
| Form EFFECT CONDUIT PHARMACEUTICALS | SEC filing · Form EFFECT | +1.16% | +8.44% | |
| Form S-1/A CONDUIT PHARMACEUTICALS | SEC filing · Form S-1 | +1.69% | -0.38% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Sep 06 | SEC filing · Form 8-K | -2.44% | -1.57% | |
| Form S-1 CONDUIT PHARMACEUTICALS | SEC filing · Form S-1 | +1.32% | +2.72% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Aug 15 | SEC filing · Form 8-K | +1.90% | +3.40% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +1.92% | -19.12% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Aug 07 | SEC filing · Form 8-K | -11.32% | -55.13% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | -11.32% | -55.13% | |
| Form 8-K/A CONDUIT PHARMACEUTICALS For: Jul 01 | SEC filing · Form 8-K | -4.77% | -15.32% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: Jul 01 | SEC filing · Form 8-K | +3.17% | -6.46% | |
| Form 8-K CONDUIT PHARMACEUTICALS For: May 28 | SEC filing · Form 8-K | +0.00% | +1.01% | |
| Form 10-Q CONDUIT PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.36% |
Keep exploring
More CDT: earnings → · analyst actions → · CDT overview →